MPS informs about earnings presentation

16 May 2023 Evaluate

Pursuant to the provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, MPS has informed that it enclosed the Earnings Presentation on Audited Financial Results of the Company for the Fourth Quarter (Q4) and Financial Year ended 31 March 2023.

The above information is a part of company’s filings submitted to BSE.

MPS Pharmaa Share Price

3.21 0.00 (0.00%)
22-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.